MEI Pharma reports exercise of pre-funded warrants for 2.08M shares of common stock

Lite Strategy, Inc.

Investor exercised Pre-Funded Warrants to purchase 2,084,509 shares of common stock on July 24, 2025.
Exercise price paid in cash was $208.45 in aggregate, representing a nominal per-share price.
Warrants were issued under the PIPE Offering initially disclosed on July 17, 2025, with exercise price of $3.4199 per warrant.
Shares were issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D exemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.